Search Result "CIP4"
Inhibition of Cdc42-Interacting Protein 4 (CIP4) Impairs Osteosarcoma Tumor Progression
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 1 Year: 2013 Page: 48-56
Author(s): Nadezhda V. Koshkina,Ge Yang,Eugenie S. Kleinerman
Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 32 Year: 2017 Page: 3485-3507
Author(s): Byron J. Aguilar,Huchen Zhou,Qun Lu
Storage, Expression and Function of Fas Ligand, the Key Death Factor of Immune Cells
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2008 Page: 1684-1696
Author(s): Marcus Lettau, Maren Paulsen, Dieter Kabelitz, Ottmar Janssen
Vesicular Transport Machinery in Brain Endothelial Cells: What We Know and What We Do not
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 13 Year: 2020 Page: 1405-1416
Author(s): Andrea E. Toth,Mikkel R. Holst,Morten S. Nielsen
Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2913-2920
Author(s): F. Condorelli, E. Stec-Martyna, J. Zaborowska, L. Felli, I. Gnemmi, M. Ponassi, C. Rosano
Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review
Journal: Current Genomics
Volume: 11 Issue: 7 Year: 2010 Page: 519-527
Author(s): Elisabeth J. Smith, Florence Allantaz, Lynda Bennett, Dongping Zhang, Xiaochong Gao, Geryl Wood, Daniel L. Kastner, Marilynn Punaro, Ivona Aksentijevich, Virginia Pascual, Carol A. Wise
Implication of Rho GTPases in Neurodegenerative Diseases
Journal: Current Drug Targets
Volume: 12 Issue: 8 Year: 2011 Page: 1202-1215
Author(s): Judith Antoine-Bertrand, Josee-France Villemure, Nathalie Lamarche-Vane
Insulin Signaling Pathways Regulating Translocation of GLUT4
Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5 Issue: 2 Year: 2005 Page: 159-165
Author(s): Maria R. Ver, Hui Chen, Michael J. Quon
Diseases and Disorders Associated with Immune System
Ebook: Natural Immunomodulators: Promising Therapy for Disease Management
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815123258123010005
Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 8 Year: 2010 Page: 840-848
Author(s): H.-W. Lo